No reported Insider Trades available for OrbiMed Asia IV Mauritius FVCI Ltd in the Trendlyne database.
OrbiMed Asia IV Mauritius FVCI Ltd's has made SAST transactions in Marksans Pharma Ltd. recently where a Disposal of 10,273,443 shares done . Disclosure was reported to the exchange on June 13, 2025.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Marksans Pharma | OrbiMed Asia IV Mauritius FVCI Ltd | Other | Disposal | 09 Jul 2025 | 10,273,443 | 39,050,881 (8.62%) | 2.27% | - | 11 Jun 2025 11 Jun 2025 |
SAST (29(2)) | - | Market | |
| Marksans Pharma | OrbiMed Asia IV Mauritius FVCI Ltd | Other | Acquisition | 25 Jan 2023 | 49,324,324 | 49,324,324 (10.88%) | 10.88% | - | 20 Jan 2023 20 Jan 2023 |
SAST (29(1)) | - | Conv. of Warrants |